Pirtobrutinib: a promising therapy for overcoming the resistance of ibrutinib in mantle cell lymphoma

被引：0
|
作者：
Fatima, Sania Kaneez [1 ]
Khan, Sara [1 ]
Mughal, Zaib Un Nisa [1 ]
Rangwala, Hussain Sohail [1 ]
Rangwala, Burhanuddin Sohail [1 ]
Siddiq, Mohammad Arham [1 ]
Ali, Mirha [1 ]
Farah, Asma Ahmed [2 ,3 ]
机构：
[1] Jinnah Sindh Med Univ, Dept Med, Karachi, Pakistan
[2] East Africa Univ, Dept Med, Bosaso, Somalia
[3] East Africa Univ, 66R3 CC4, Boosaaso, Somalia
来源：
ANNALS OF MEDICINE AND SURGERY | 2024年 / 86卷 / 06期
关键词：
INHIBITOR; BRUIN;
D O I：
10.1097/MS9.0000000000002045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3189 / 3191
页数：3
相关论文
共 50 条
  • [21] The Development of a Precision Medicine Platform to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
    Liu, Yang
    Zhao, Shuangtao
    Jiang, Changying
    Yao, Yixin
    Murfin, Kelley Paige
    Grundman, Hadley
    Zhang, Liang
    Nomie, Krystle
    Wang, Linghua
    Wang, Michael
    BLOOD, 2019, 134
  • [22] HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma
    Jacobson, Caron
    Kopp, Nadja
    Layer, Jacob V.
    Redd, Robert A.
    Tschuri, Sebastian
    Haebe, Sarah
    van Bodegom, Diederik
    Bird, Liat
    Christie, Amanda L.
    Christodoulou, Alexandra
    Saur, Amy
    Tivey, Trevor
    Zapf, Stefanie
    Bararia, Deepak
    Zimber-Strobl, Ursula
    Rodig, Scott J.
    Weigert, Oliver
    Weinstock, David M.
    BLOOD, 2016, 128 (21) : 2517 - 2526
  • [23] Developing Novel Therapeutic Strategies to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
    Lan Pham
    Zhang, Liang
    Tao, Wenjing
    Zhao, Donglu
    Zhang, Hui
    Xie, Jingmeng
    Wang, Jack
    Nomie, Krystle
    Wang, Michael
    BLOOD, 2015, 126 (23)
  • [24] Mantle cell lymphoma of the iris treated by ibrutinib
    De Gauzy, T. Sales
    Oberic, L.
    Fournie, P.
    Soler, V.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2018, 41 (10): : E501 - E502
  • [25] Genetically Defined Metabolic Targets Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
    Zhang, Liang
    Guo, Hui
    Zhang, Hui
    Yao, Yixin
    Liu, Yang
    Zhang, Shaojun
    Rui, Lixin
    Wang, Linghua
    Nomie, Krystle
    Wang, Michael L.
    BLOOD, 2019, 134
  • [26] Oncogenic MALT1 Promotes Cell Survival and Mediates Ibrutinib Resistance and Ibrutinib-Venetoclax Resistance in Mantle Cell Lymphoma
    Jiang, Vivian Changying
    Lian, Junwei
    Huang, Shengjian
    Zhang, Shaojun
    Liu, Yang
    Wang, Linghua
    Wang, Michael
    BLOOD, 2020, 136
  • [27] Mechanism of action of Ibrutinib in mantle cell lymphoma
    Sun, Zhijian
    Zhou, Dongping
    Wei, Min
    Luo, Lusong
    CANCER RESEARCH, 2014, 74 (19)
  • [28] UHRFI Is a Promising Therapy Target in Aggressive Mantle Cell Lymphoma
    Yang, Yuan
    Yang, Ping
    Zhang, Weilong
    Wang, Jing
    Chen, Yingtong
    Li, Chunyuan
    Jing, Hongmei
    BLOOD, 2024, 144 : 5753 - 5753
  • [29] Promising Results of Ibrutinib in Three Patients with Secondary Central Nervous System Mantle Cell Lymphoma
    Bernard, Sophie
    Goldwirt, Lauriane
    Amorim, Sandy
    Brice, Pauline
    Briere, Josette
    Sauvageon, Helene
    Thieblemont, Catherine
    BLOOD, 2014, 124 (21)
  • [30] Overcoming Drug Resistance in Mantle Cell Lymphoma Using a Combination of Dose-Dense and Intense Therapy
    Crout, Christopher A.
    Koh, Liang-Piu
    Gockerman, Jon P.
    Moore, Joseph O.
    DeCastro, Carlos
    Long, Gwynn D.
    Diehl, Louis
    Gasparetto, Christina
    Niedzwiecki, Donna
    Edwards, Jon
    Prosnitz, Leonard
    Horwitz, Mitchell
    Chute, Jon
    Morris, Ashley
    Davis, Patricia
    Beaven, Anne
    Chao, Nelson J.
    Ali-Osman, Francis
    Rizzieri, David A.
    CANCER INVESTIGATION, 2010, 28 (06) : 654 - 660
12345